Zimmerman Mark, Kerr Sophie, Balling Caroline, Kiefer Reina, Dalrymple Kristy
Brown Medical School, Providence, RI 02904 USA. E-MAIL:
Ann Clin Psychiatry. 2020 Feb;32(1):5-11.
We examined whether a self-report measure of the DSM-5 anxious distress specifier, the Clinically Useful Depression Outcome Scale Anxious Distress Specifier Subscale (CUDOS-A), was as valid as a broader measure of the severity of anxiety, the Clinically Useful Anxiety Outcome Scale (CUXOS), in patients with depression.
Two hundred ninety-four patients with major depressive disorder were administered a semi-structured interview. The patients completed self-report measures of depression, anxiety, and irritability. Sensitivity to change was examined in a subset of patients.
Both the CUDOS-A and CUXOS were more highly correlated with measures of anxiety than with measures of the other symptom domains. Patients with anxiety disorders scored significantly higher on both measures than did patients with no current anxiety disorder. Both measures were equally correlated with measures of coping, general well-being, and functioning. A large effect size of treatment was found for both measures (CUDOS-A: d = 1.2; CUXOS: d = 1.3).
Both the CUDOS-A and CUXOS were valid self-report measures of anxiety symptom severity in patients with depression. Because anxiety is common in patients with depression, the addition of a small number of items assessing the DSM-5 anxious distress criteria should be added to depression measures and used in measurement-based care efforts.
我们研究了《精神疾病诊断与统计手册》第5版(DSM - 5)中焦虑痛苦特征的一种自我报告测量工具,即临床有用的抑郁结果量表焦虑痛苦特征子量表(CUDOS - A),在抑郁症患者中是否与一种更广泛的焦虑严重程度测量工具,即临床有用的焦虑结果量表(CUXOS)一样有效。
对294名重度抑郁症患者进行了半结构化访谈。患者完成了关于抑郁、焦虑和易怒的自我报告测量。在一部分患者中检查了对变化的敏感性。
CUDOS - A和CUXOS与焦虑测量指标的相关性均高于与其他症状领域测量指标的相关性。焦虑症患者在这两种测量指标上的得分均显著高于当前无焦虑症的患者。这两种测量指标与应对、总体幸福感和功能的测量指标的相关性相同。两种测量指标均发现有较大的治疗效应量(CUDOS - A:d = 1.2;CUXOS:d = 1.3)。
CUDOS - A和CUXOS都是抑郁症患者焦虑症状严重程度的有效自我报告测量工具。由于焦虑在抑郁症患者中很常见,应在抑郁测量工具中增加少量评估DSM - 5焦虑痛苦标准的条目,并用于基于测量的护理工作中。